Main > A2. TRADEMARK. INDEX. Vn-Vz > Vyzulta

Product USA. B

GENERIC NAME latanoprostene bunod ophthalmic solution, 0.024%
INDICATION'S Ophthalmo>Glaucoma
STATUS Approved in: AR; BR; CA; HK; MX; TW & Ukraine
Launched in: USA
UPDATE 2021. 04.16
COMPANY This data is not available for free
PATENT ASSIGNEE This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back